Stage III HR-Positive Breast Cancer: Christine's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Biomarkers
- ER-positive; PR-positive; HER2-positive
- Sex
- Female
- Treatment
- fertility preservation, chemotherapy, surgery and radiation
- Outcome
- Survivorship / Surveillance
Treatment course, step by step
- Embryo freezing before treatment, producing 2 healthy embryos → 4 rounds of doxorubicin plus cyclophosphamide → 12 weekly paclitaxel treatments, for about 5 months of chemotherapy → 1-month recovery break → lumpectomy after the tumor shrank from nearly 8 cm to 1.2 cm → radiation therapy.
What happened, in summary
Christine was 31 when she noticed a visible divot and a large, hard, immovable lump in her breast. Imaging and biopsy confirmed stage 3 triple-positive breast cancer. MRI measured the tumor at nearly 8 cm and showed at least 2 involved lymph nodes, with 4 suspected.
Because chemotherapy could affect fertility, Christine delayed treatment by about 2.5 weeks to complete embryo freezing. She and her husband obtained 2 healthy embryos. About 1 month after diagnosis, she began 4 rounds of doxorubicin and cyclophosphamide, followed by 12 weekly paclitaxel treatments. The full chemotherapy course lasted about 5 months.
Chemotherapy was physically and emotionally difficult, especially hair loss, nausea, fatigue, steroid-related changes and the fear of long-term effects. Christine combined standard treatment with supportive integrative care discussed with her oncology team.
After chemotherapy, the tumor had shrunk from almost 8 cm to 1.2 cm. Following a 1-month recovery break, she chose a lumpectomy rather than mastectomy and later completed radiation. Three years after diagnosis, she described the emotional challenges of survivorship, including radiation burns, surgical scarring, body-image changes and delayed trauma after active treatment ended. Her experience helped her become more present in daily life and more willing to ask for help.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer